BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• BioMidwest

  Nanosphere, Inc. Prices $26.3 Million Public Offering of Common Stock

  September 13, 2013

   · 

  4 min read
• Business

  FDA Rejects Delcath Systems, Inc.'s Cancer Therapy, Fires CEO

  September 13, 2013

   · 

  1 min read
• Drug Development

  Stem Cell Theranostics’ “Clinical-Trial-in-a-Dish” Wows

  September 13, 2013

   · 

  1 min read
• Job Trends

  PSS World Medical Lays Off 124

  September 13, 2013

   · 

  1 min read
• BioForest

  Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants

  September 13, 2013

   · 

  3 min read
• BioForest

  Cell Therapeutics, Inc. Announces Sale of Convertible Preferred Stock

  September 13, 2013

   · 

  5 min read
• BioCapital

  New Stain-Free Gel Visualization Application of Syngene’s G:BOX System Helps Save Time and Make Protein Analysis Safer

  September 13, 2013

   · 

  2 min read
• Drug Development

  PRANA Biotechnology Updates Progress on PBT2 Trials in Alzheimer’s and Huntington’s Diseases

  September 13, 2013

   · 

  4 min read
• Drug Development

  Versartis, Inc. Receives Orphan Drug Status for Its Novel Long-Acting Growth Hormone Treatment From European Commission (EC)

  September 13, 2013

   · 

  3 min read
• Business

  Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis

  September 13, 2013

   · 

  1 min read